Location History:
- Waltham, MA (US) (2016)
- Sudbury, MA (US) (2010 - 2017)
Company Filing History:
2 out of 850 
2 out of 11 Years Active: 2010-2017
Title: Brendan Chen: Innovator in Beta-Lactamase Inhibitor Compounds
Introduction
Brendan Chen is a notable inventor based in Sudbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitor compounds. With a total of 4 patents to his name, Chen's work is crucial in addressing bacterial infections, especially those caused by drug-resistant organisms.
Latest Patents
Chen's latest patents focus on compounds that serve as beta-lactamase inhibitors. These compounds, along with their pharmaceutically acceptable salts, are designed to be used in combination with beta-lactam antibiotics or alone for the treatment of bacterial infections. This includes infections caused by multi-drug resistant organisms. The present invention includes compounds according to a specific formula, which is detailed in his patent documentation.
Career Highlights
Throughout his career, Brendan Chen has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Millennium Pharmaceuticals Limited and Entasis Therapeutics, Inc. His work in these organizations has allowed him to contribute to innovative solutions in combating bacterial infections.
Collaborations
Chen has collaborated with several professionals in his field, including Paul E Fleming and Zhan Shi. These collaborations have likely enhanced the development and application of his inventions.
Conclusion
Brendan Chen's contributions to the field of pharmaceuticals, particularly through his patents on beta-lactamase inhibitors, highlight his role as an innovator. His work is essential in the ongoing battle against drug-resistant bacterial infections.